Details for New Drug Application (NDA): 206890
✉ Email this page to a colleague
NDA 206890 describes ILOPERIDONE, which is a drug marketed by Inventia, Lupin Ltd, and Taro, and is included in three NDAs. It is available from two suppliers. Additional details are available on the ILOPERIDONE profile page.
The generic ingredient in ILOPERIDONE is iloperidone. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iloperidone profile page.
The generic ingredient in ILOPERIDONE is iloperidone. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iloperidone profile page.
Summary for 206890
| Tradename: | ILOPERIDONE |
| Applicant: | Lupin Ltd |
| Ingredient: | iloperidone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | May 5, 2022 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | May 5, 2022 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 4MG | ||||
| Approval Date: | May 5, 2022 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
